Aromasin Exemestane Research Overview
Aromasin 25 mg is a steroidal aromatase inhibitor manufactured by Intex Pharma, representing an irreversible third-generation pharmaceutical compound for advanced endocrinological research. As an exemestane-based formulation, this research chemical offers investigators a mechanism-based enzyme inhibitor that permanently inactivates the aromatase complex through covalent binding. Unlike reversible inhibitors, exemestane forms a stable intermediate with the aromatase enzyme, making it particularly valuable for studies examining sustained estrogen suppression in laboratory models. Researchers at Stroid UK Shop utilize this compound extensively for investigating steroidogenesis pathways and hormonal regulatory mechanisms.
Scientific Investigation Applications
Research scientists examine Aromasin’s unique steroidal structure and its implications for selective enzyme inhibition studies. The compound’s androgenic partial agonist properties distinguish it from non-steroidal alternatives, providing researchers with opportunities to study dual-mechanism effects in cellular models. Laboratory investigations frequently focus on the compound’s ability to reduce estrogen synthesis while potentially exhibiting mild androgenic activity through metabolite formation. Studies within aromatase inhibitor research demonstrate exemestane’s irreversible binding mechanism, making it an essential tool for examining permanent enzyme modification effects. Comparative analyses with other research compounds available through SARM studies and peptide investigations reveal distinct pharmacological profiles suitable for diverse experimental designs.
Research Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Exemestane |
| Concentration | 25 mg per unit |
| Manufacturer | Intex Pharma |
| Classification | Steroidal Aromatase Inhibitor |
| CAS Number | 107868-30-4 |
| Molecular Formula | C₂₀H₂₄O₂ |
| Molecular Weight | 296.4 g/mol |
| Storage | Room temperature, dry conditions |
Laboratory Compliance
This Aromasin exemestane formulation is supplied exclusively for in-vitro research applications and laboratory analysis. The compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must maintain appropriate safety protocols and institutional approval for all investigational studies. Laboratory personnel should ensure proper storage conditions and handling procedures according to institutional guidelines for research chemical management.
